Problems in identifying functional erythropoietin receptors in cancer tissue.
Jelkmann
Wolfgang
W
Laugsch
Magdalena
M
D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D018450:Disease Progression; D004921:Erythropoietin / Q000494:pharmacology*; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007150:Immunohistochemistry; D009389:Neovascularization, Pathologic; D011379:Prognosis; D017467:Receptors, Erythropoietin / Q000235:genetics / Q000378:metabolism*; D012307:Risk Factors; D012680:Sensitivity and Specificity; D014407:Tumor Cells, Cultured / Q000187:drug effects
D014408:Biomarkers, Tumor; D017467:Receptors, Erythropoietin; D004921:Erythropoietin